NASDAQ:DCGO
DocGo Inc. Stock News
$3.39
+0.0100 (+0.296%)
At Close: May 01, 2024
DocGo to Announce First Quarter 2024 Results on Wednesday, May 8, 2024
07:35am, Monday, 22'nd Apr 2024
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release
DocGo, Inc. (DCGO) Q4 2023 Earnings Call Transcript
09:04pm, Wednesday, 28'th Feb 2024
DocGo, Inc. (DCGO) Q4 2023 Earnings Call Transcript
DocGo Inc. (DCGO) Q4 Earnings Lag Estimates
07:06pm, Wednesday, 28'th Feb 2024
DocGo Inc. (DCGO) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.11 per share a year ago.
DocGo to Announce Fourth Quarter and Full Year 2023 Results on Wednesday, February 28, 2024
07:35am, Tuesday, 13'th Feb 2024
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release
DocGo Announces Participation at Two Upcoming Investor Conferences
07:35am, Monday, 05'th Feb 2024
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor c
Fuzzy Panda Slams DocGo (DCGO) Stock in New Short Report
12:00pm, Wednesday, 10'th Jan 2024
Shares of DocGo (NASDAQ: DCGO ), a company known for its mobile medical services, are plunging lower following the publication of a short report by Fuzzy Panda. The short seller has accused the compan
DocGo: Growth Significantly Exceeded My Expectations
07:51am, Thursday, 30'th Nov 2023
I believe DCGO remains undervalued and has strong growth prospects. Recent results show significant revenue growth and an increase in FY23 revenue guidance. Despite concerns about contract rejection,
DocGo Announces Attendance at November 2023 Investor Conferences
07:35am, Wednesday, 08'th Nov 2023
NEW YORK--(BUSINESS WIRE)--DocGo, a leading provider of technology-enabled mobile health services (Nasdaq: DCGO), today announced that the company will be participating in the following investor confe
DocGo to Announce Third Quarter 2023 Results on Monday, November 6, 2023
07:35am, Monday, 23'rd Oct 2023
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that the Company will release
Why DocGo Stock Plummeted by 7% on Monday
06:21pm, Monday, 18'th Sep 2023
Its CEO resigned abruptly. His official bio stated falsely that he earned a master's degree in artificial intelligence (AI).
DocGo Inc. (DCGO) Moves 6.8% Higher: Will This Strength Last?
09:46am, Friday, 15'th Sep 2023
DocGo Inc. (DCGO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
DocGo: Preventing Onboarding Problem From Turning Into A Crisis (Rating Downgrade)
10:36pm, Monday, 11'th Sep 2023
DocGo was rewarded a no-bid contract by the NYC to provide medical care for the migrants, but this large contract is facing the risk of being revoked as of late. The management took the direction to b
Why Shares of DocGo Are Slumping Wednesday
03:16pm, Wednesday, 06'th Sep 2023
DocGo improved revenue in the second quarter. The company has added major contracts this year with EmblemHealth and Carnival Cruise Lines.
DocGo Announces Upcoming Participation in Three Investor Conferences in September
07:35am, Tuesday, 05'th Sep 2023
NEW YORK--(BUSINESS WIRE)--DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, Chief Executive Officer will present at three differen
DocGo Inc. (DCGO) Q2 2023 Earnings Call Transcript
10:26pm, Monday, 07'th Aug 2023
DocGo Inc. (NASDAQ:DCGO ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Corporate Participants Mike Cole - Director-Investor Relations Anthony Capone - Chief Executive Officer Lee Biensto